IRIS
SMIRNE, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.925
NA - Nord America 1.503
AS - Asia 395
AF - Africa 7
SA - Sud America 1
Totale 3.831
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.490
IE - Irlanda 596
IT - Italia 302
SE - Svezia 302
DE - Germania 254
UA - Ucraina 188
CN - Cina 130
FR - Francia 112
HK - Hong Kong 112
FI - Finlandia 108
SG - Singapore 65
IN - India 54
CZ - Repubblica Ceca 20
GB - Regno Unito 20
VN - Vietnam 17
BE - Belgio 14
CA - Canada 13
IR - Iran 9
KE - Kenya 5
PH - Filippine 3
TR - Turchia 3
CH - Svizzera 2
EG - Egitto 2
RO - Romania 2
RS - Serbia 2
RU - Federazione Russa 2
CL - Cile 1
ID - Indonesia 1
IL - Israele 1
MK - Macedonia 1
Totale 3.831
Salva come PNG Salva come JPEG
Città #
Dublin 596
Jacksonville 359
Dearborn 166
Chandler 152
Hong Kong 110
Wilmington 90
Ann Arbor 81
Piemonte 76
Lawrence 71
Princeton 71
San Mateo 58
Beijing 49
Andover 41
Singapore 38
Milan 33
Ashburn 32
Novara 30
Brno 20
Nanjing 17
Turin 17
Dong Ket 16
Boardman 15
Brussels 14
Helsinki 14
Woodbridge 13
Hefei 12
Norwalk 11
Houston 10
Düsseldorf 9
Philadelphia 9
Bremen 8
Munich 8
Grafing 7
Strasbourg 7
Berlin 6
Fairfield 6
Jinan 6
Kunming 6
Rome 6
Seattle 6
Monmouth Junction 5
Nairobi 5
Naples 5
Toronto 5
Alessandria 4
Augusta 4
Fuzhou 4
Guangzhou 4
Palermo 4
West Jordan 4
Brescia 3
Kocaeli 3
Pioltello 3
Redwood City 3
Shenyang 3
Torino 3
Wuhan 3
Appiano Gentile 2
Bagnoli del Trigno 2
Bucharest 2
Bulandshahr 2
Busalla 2
Caloocan City 2
Casaleggio Novara 2
Cassano Magnago 2
Frankfurt am Main 2
Ghemme 2
Giugliano In Campania 2
Guanzate 2
Hebei 2
Leawood 2
Los Angeles 2
Lucca 2
Nanning 2
Ningbo 2
Paris 2
Quzhou 2
Romainville 2
Saint-Fons 2
San Diego 2
Senago 2
Shanghai 2
Vercelli 2
Zanjan 2
Ardabil 1
Bangalore 1
Baotou 1
Cairo 1
Cambridge 1
Casavatore 1
Castelli Calepio 1
Cento 1
Central 1
Central District 1
Concepción 1
Falconara Marittima 1
Filottrano 1
Giarre 1
Gunzenhausen 1
Hangzhou 1
Totale 2.431
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 140
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 98
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 92
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 89
The surgical treatment of lung metastases. The prognostic factors and the indications for the surgical approach 83
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 80
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 80
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 75
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 75
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 74
Diagnostic value of FibroTest with normal serum aminotransferases 66
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 66
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 66
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 65
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 65
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 65
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma 63
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 61
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 60
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 60
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 59
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 59
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 58
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C 58
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 58
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 58
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 56
Vascular endothelial growth factor. From basic research to clinical application 56
ACE genotype, body weight changes and target organ damage in renal transplant recipients 55
Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2 54
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 54
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 54
Acquired post partum hemophilia 53
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 52
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells 51
Sexually transmitted diseases and pelvic inflammatory disease 49
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 48
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 48
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 48
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 47
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 47
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 47
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 46
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 45
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 44
Imatinib mesylate for the treatment of solid tumours: Recent trials and future directions 44
Chlamydia trachomatis prevalence in North-West Italy 43
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes 43
Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C 42
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 42
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 42
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response 42
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report 42
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 41
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 41
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 41
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application 41
Imatinib mesilate: New perspectives in the treatment of solid tumours 40
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 40
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential 39
The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects 39
Imatinib mesylate: new perspectives in the treatment of solid tumours 39
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 39
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 38
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. 37
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients 36
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 36
Use, misuse and abuse of diuretics 36
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 35
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 35
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose 34
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 25
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 18
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. 11
Unveiling the Mystery of Adult-Onset Still’s Disease: A Compelling Case Report 10
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 4
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection 1
Totale 3.923
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020751 4 11 69 3 125 114 141 49 82 76 69 8
2020/2021499 62 0 63 3 79 26 72 4 73 20 72 25
2021/2022570 12 22 93 58 35 15 64 19 48 28 67 109
2022/20231.263 141 55 67 33 65 130 27 71 611 6 43 14
2023/2024487 35 54 35 15 87 8 91 17 14 11 42 78
2024/202525 25 0 0 0 0 0 0 0 0 0 0 0
Totale 3.923